Financials

688302 fundamentals

An in-depth look to HINOVA PHARMACEUTICALS INC operating, investing, and financing activities

688302 free cash flow for Q1 25 is -60.98 M CNY. For 2024, 688302 free cash flow was -262.6 M CNY and operating cash flow was -173.05 M CNY.

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Cash from operating activities

Cash from investing activities

Cash from financing activities

Currency: CNY